RISK FACTOR PREDICTIVE OF TRANSPLANT FREE SURVIVAL IN A LARGE COHORT OF PSC PATIENTS IN THE UK by Srivastava, B, Spiess, K, Brown, M, Muriithi, A, Dawwas, M, Alexander, G, Sandford, R, Rushbrook, S, Chapman, R, Consortium, UK-PSC

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System by Goode, EC, Clark, AB, Mells, GF, Srivastava, B, Spiess, K, Gelson, WTH, Trivedi, PJ, Lynch, KD, Castren, E, Vesterhus, MN, Karlsen, TH, Ji, S-G, Anderson, CA, Thorburn, D, Hudson, M, Heneghan, MA, Aldersley, MA, Bathgate, A, Sandford, RN, Alexander, GJ, Chapman, RW, Walmsley, M, Uk-PSC Consortium, Hirschfield, GM, Rushbrook, SM

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease by Ji, S-G, Juran, BD, Mucha, S, Folseraas, T, Jostins, L, Melum, E, Kumasaka, N, Atkinson, EJ, Schlicht, EM, Liu, JZ, Shah, T, Gutierrez-Achury, J, Boberg, KM, Bergquist, A, Vermeire, S, Eksteen, B, Durie, PR, Farkkila, M, Müller, T, Schramm, C, Sterneck, M, Weismüller, TJ, Gotthardt, DN, Ellinghaus, D, Braun, F, Teufel, A, Laudes, M, Lieb, W, Jacobs, G, Beuers, U, Weersma, RK, Wijmenga, C, Marschall, H-U, Milkiewicz, P, Pares, A, Kontula, K, Chazouillères, O, Invernizzi, P, Goode, E, Spiess, K, Moore, C, Sambrook, J, Ouwehand, WH, Roberts, DJ, Danesh, J, Floreani, A, Gulamhusein, AF, Eaton, JE, Schreiber, S, Chapman, RW, Et al.